###begin article-title 0
###xml 4 13 4 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Int7G24A </italic>
The Int7G24A variant of transforming growth factor-beta receptor type I is a risk factor for colorectal cancer in the male Spanish population: a case-control study
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 4 13 4 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Int7G24A </italic>
###xml 72 81 72 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(TGFBR1) </italic>
###xml 291 297 291 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBR1</italic>
###xml 298 307 298 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Int7G24A </italic>
###xml 336 343 <span type="species:ncbi:9606">patient</span>
The Int7G24A variant of transforming growth factor-beta receptor type I (TGFBR1) has been shown to increase the risk for kidney, ovarian, bladder, lung and breast cancers. Its role in colorectal cancer (CRC) has not been established. The aims of this study were to assess the association of TGFBR1*Int7G24A variant with CRC occurrence, patient age, gender, tumour location and stage.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
We performed a case-control study with 504 cases of sporadic CRC; and 504 non-cancerous age, gender and ethnically matched controls. Genotyping analysis was performed using allelic discrimination assay by real time PCR.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 4 13 4 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Int7G24A </italic>
###xml 102 104 102 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 170 179 170 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Int7G24A </italic>
###xml 257 266 257 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Int7G24A </italic>
###xml 397 399 397 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 307 310 <span type="species:ncbi:9606">men</span>
###xml 432 437 <span type="species:ncbi:9606">women</span>
The Int7G24A variant was associated with increased CRC incidence in an additive model of inheritance (P for trend = 0.005). No significant differences were found between Int7G24A genotypes and tumour location or stage. Interestingly, the association of the Int7G24A variant with CRC risk was significant in men (odds ratio 4.10 with 95% confidence intervals 1.41-11.85 for homozygous individuals; P for trend = 0.00023), but not in women. We also observed an increase in susceptibility to CRC for individuals aged less than 70 years.
###end p 6
###begin title 7
Conclusion
###end title 7
###begin p 8
###xml 26 35 26 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Int7G24A </italic>
Our data suggest that the Int7G24A variant represents a risk factor for CRC in the male Spanish population.
###end p 8
###begin title 9
Background
###end title 9
###begin p 10
###xml 316 317 310 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
Transforming growth factor beta (TGF-beta) is one of the most potent inhibitors of proliferation in epithelial, neuronal and hematopoietic cells. The effects of an activated TGF-beta signalling pathway include inhibition of cell cycle progression, promotion of terminal differentiation and activation of cell death [1].
###end p 10
###begin p 11
###xml 37 43 34 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBR1</italic>
###xml 267 268 258 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 382 383 373 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 553 554 544 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 567 574 558 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBR1 </italic>
###xml 681 691 672 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBR1*6A </italic>
###xml 887 888 878 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 988 989 979 980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 990 991 981 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
TGF-beta receptor type I (encoded by TGFBR1) is a mediator of TGF-beta growth inhibitory signals. Extracellular TGF-beta binds first to the type II receptor, which then dimerizes and activates the type I receptor, sending the signal to the nucleus via SMAD proteins [1]. Abnormalities of this signalling pathway are almost universal in cancer cells through a variety of mechanisms [2]. Among them are overexpression of the ligands, downregulation of receptors, and point mutations and deletions in the genes coding for proteins involved in the pathway [3]. Different TGFBR1 allelic variants have been associated with susceptibility to develop different types of tumours. Thus, the TGFBR1*6A allele, located at exon 1 (rs11466445) has been shown to be a susceptibility allele for colorectal cancer (CRC), breast and ovarian cancers, based on a meta-analysis of many case-control studies [4]. In contrast, one recent report found a lack of an association between this variant and CRC risk [5,6]. The role of this variant in CRC susceptibility remains controversial.
###end p 11
###begin p 12
###xml 4 10 4 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBR1</italic>
###xml 11 20 11 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Int7G24A </italic>
###xml 197 206 197 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Int7G24A </italic>
###xml 366 367 366 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 368 370 368 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 483 485 483 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
The TGFBR1_Int7G24A polymorphism (rs334354; NM_004612.2:c.1255+24G>A) has also been associated with cancer risk, but the function of this variant has yet to be discovered. Individuals carrying the Int7G24A variant have an increased risk of developing non-small cell lung cancer, renal cell carcinomas, transitional cell carcinomas of the bladder, and breast cancer [7-10]. To our knowledge, there is only one published report on the association between this genetic variant and CRC [11]. In that study, there was no evidence of an association between this polymorphism and colorectal cancer risk in familial cases.
###end p 12
###begin p 13
###xml 20 29 20 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Int7G24A </italic>
###xml 259 268 259 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Int7G24A </italic>
###xml 457 466 457 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Int7G24A </italic>
###xml 348 355 <span type="species:ncbi:9606">patient</span>
###xml 561 564 <span type="species:ncbi:9606">men</span>
To test whether the Int7G24A variant might be associated with the incidence of CRC in the Spanish population, we carried out a case-control study with 504 cases and 504 matched controls for age, gender and ethnicity. We found a significant association of the Int7G24A variant with the incidence of CRC. It also showed significant associations with patient gender (male) and age, but not with tumour location or stage. These data support the hypothesis that Int7G24A variant may be a low penetrance tumour susceptibility allele that predisposes to CRC mainly in men in the Spanish population.
###end p 13
###begin title 14
Methods
###end title 14
###begin title 15
Study subjects
###end title 15
###begin p 16
###xml 205 212 <span type="species:ncbi:9606">patient</span>
###xml 260 268 <span type="species:ncbi:9606">Patients</span>
###xml 332 340 <span type="species:ncbi:9606">patients</span>
###xml 438 446 <span type="species:ncbi:9606">patients</span>
A total of 504 sporadic cases of CRC and 504 controls from the Elche University Hospital and Castellon Provincial Hospital tissue banks were analysed in this study. Written consent was obtained from every patient to be included in the respective tissue banks. Patients diagnosed with a familial cancer syndrome were excluded. Thus, patients with Amsterdam II criteria for hereditary non-polyposis colorectal cancer were excluded, as were patients with Bethesda criteria and who were negative for microsatellite instability, who were studied in our genetic counselling unit.
###end p 16
###begin p 17
###xml 270 278 <span type="species:ncbi:9606">patients</span>
This was a hospital-based case-control study. Controls were selected from the same hospitals with no personal history of cancer and selected according to diagnoses unrelated to the disease of interest. They were matched for age, gender and race/ethnicity with the study patients. The study was approved by the Ethics Committees from the Elche University and Castellon Provincial hospitals.
###end p 17
###begin p 18
###xml 19 27 <span type="species:ncbi:9606">patients</span>
###xml 150 158 <span type="species:ncbi:9606">patients</span>
###xml 188 191 <span type="species:ncbi:9606">men</span>
###xml 202 207 <span type="species:ncbi:9606">women</span>
The median age for patients with CRC at diagnosis was 70 years (range 23-92); for controls it was 72 years (range 23-98). Gender distribution for the patients with CRC ('cases') was 59.4% men and 40.6% women; for controls, it was 53.3% and 46.7%, respectively. In 33.3% of the cases, tumours were in the proximal colon and 66.7% were located at the distal colon and rectum; 45% were classified as low stage (I and II) and 55% as high stage (III and IV). The numbers of cases and controls for whom information was unavailable for stratification were 64 and one, respectively.
###end p 18
###begin title 19
DNA and RNA isolation and cDNA synthesis
###end title 19
###begin p 20
Control DNA samples were obtained from peripheral blood samples. DNA samples from cases were isolated after mechanical homogenization of non-cancerous frozen colorectal tissue. DNA isolation was performed using an EZ1 BioRobot (Qiagen, Valencia, CA, USA) according to the manufacturer's instructions. RNA was isolated from normal colon tissue of selected cases in the same manner. Synthesis of cDNA was performed using random primers and Reverse Transcription reagents (Applied Biosystems, Foster City, CA, USA).
###end p 20
###begin title 21
###xml 15 24 15 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Int7G24A </italic>
Genotyping the Int7G24A polymorphism (rs334354)
###end title 21
###begin p 22
A total of 1008 individuals (504 cases and 504 controls) were analysed for this polymorphism. Single nucleotide polymorphism (SNP) analysis was performed using a real-time polymerase chain reaction (PCR) TaqMan assay for allelic discrimination (TaqMan SNP Genotyping Assay; ID: C_1413390_20; Applied Biosystems) with minor modifications. All PCR reactions contained 20 ng DNA, 10 muL TaqMan Universal Master Mix (Applied Biosystems), 0.5 muL of the assay and water for a final volume of 20 muL. The appropriate negative controls were also run in parallel. Real time PCR was performed on an ABI Prism 7300 Sequence Detection System (Applied Biosystems) using the following conditions: 95degreesC for 10 min and 40 cycles of amplification (95degreesC for 15 s and 60degreesC for 1 min). Software in the system was used to quantify the fluorescent signals from VIC- or FAM-labelled probes. Two representative cases for each genotype were sequenced directly to confirm the genotyping results. Sequencing reactions were performed using BigDye Terminator (version 3.1) Cycle Sequencing kits and run in an ABI Prism 3100-Avant Genetic Analyser (Applied Biosystems).
###end p 22
###begin title 23
Analysis of the lengths of Int7G24 and Int7A24 variant transcripts
###end title 23
###begin p 24
###xml 35 39 35 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G/G </italic>
###xml 61 65 61 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A/A </italic>
###xml 110 117 110 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBR1 </italic>
Four cases previously genotyped as G/G and four genotyped as A/A were analysed to compare the length of their TGFBR1 transcripts. This experiment was performed using PCR and capillary electrophoresis. Primer sequences designated IVS7cDNA-F (labelled with 6-FAM) were 5'-AAATTGCTCGACGATGTTCC-3' for exon 7, and IVS7cDNA-R, 5'-CTCTGCCATCTGTTTGGGAT-3' for exon 8. The expected size of a normal PCR product was 151 bp. Twenty-five nanograms of DNA were used in a total PCR reaction volume of 25 muL AmpliTaq Gold PCR Master Mix 2 x (Applied Biosystems) and 20 pmol of each primer. After an initial 9 min at 95degreesC, PCR was run for 40 cycles of 95degreesC for 20 s; 55degreesC for 20 s and 72degreesC for 20 s; followed by 10 min final extension at 72degreesC. Diluted (1/10) PCR products along with Genescan 500 ROX size standards in HiDi formamide (Applied Biosystems,) were resolved by capillary electrophoresis (ABI 3100 Avant, Applied Biosystems) using POP6 polymer. GeneScan Software was used for the analysis of PCR fragment lengths (Applied Biosystems).
###end p 24
###begin title 25
Statistical analysis
###end title 25
###begin p 26
###xml 208 217 208 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Int7G24A </italic>
###xml 315 319 315 319 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A/A </italic>
###xml 323 326 323 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G/A</italic>
###xml 335 338 335 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G/G</italic>
###xml 351 355 351 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G/G </italic>
###xml 359 362 359 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G/A</italic>
###xml 371 374 371 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A/A</italic>
###xml 390 393 390 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A/A</italic>
###xml 402 406 402 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G/G </italic>
###xml 410 413 410 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G/A</italic>
###xml 652 654 648 650 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
###xml 699 708 695 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Int7G24A </italic>
###xml 942 944 938 940 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 996 998 992 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 1024 1026 1020 1022 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
We first examined the Hardy-Weinberg equilibrium of allelic distribution separately for cases and controls and then compared the allele frequencies between cases and controls. We evaluated the association of Int7G24A genotypes with CRC using multivariate unconditional logistic regression models assuming dominant (A/A and G/A, versus G/G), additive (G/G and G/A, versus A/A) or recessive (A/A, versus G/G and G/A) modes of inheritance, respectively. In our basic models, we adjusted for age and gender. We explored the potential effects of modification by age in an analysis stratified by the cases' median age at diagnosis (</=70 or >70 years). A chi2 test was used to evaluate the differences in Int7G24A variant carrier frequencies between tumour and control groups for the dominant and the recessive models and to analyse any association between the SNP and clinical and pathological factors. Armitage's trend test was used to calculate P for trend in the additive model of inheritance. All P values were two-sided and P < 0.05 was considered significant. Results are expressed as the odds ratio (OR) and 95% confidence interval (CI).
###end p 26
###begin title 27
Results
###end title 27
###begin title 28
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Int7G24A </italic>
Int7G24A genotyping
###end title 28
###begin p 29
###xml 155 157 155 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 232 240 232 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Int7G24 </italic>
###xml 244 252 244 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Int7A24 </italic>
###xml 374 383 374 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Int7G24A </italic>
###xml 415 416 415 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 567 576 567 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Int7G24A </italic>
###xml 641 643 641 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 837 846 837 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Int7G24A </italic>
###xml 924 926 924 926 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 1065 1066 1065 1066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 283 291 <span type="species:ncbi:9606">patients</span>
Genotype distribution in the control and case populations did not deviate significantly from that expected for a population in Hardy-Weinberg equilibrium (P > 0.2). Allelic frequencies found in controls were 0.815 and 0.184 for the Int7G24 and Int7A24 alleles, respectively. For the patients with CRC, these frequencies were 0.764 and 0.236, respectively. Genotyping of the Int7G24A polymorphism is shown in Figure 1. The crude ORs assuming dominant, additive and recessive models of inheritance showed a significant increase of CRC risk for individuals carrying the Int7G24A variant. The best-fit model of inheritance was the additive one (P for trend = 0.005). Unconditional logistic regression adjusted for age, considering the median age for cases (70 y) as the threshold level, showed a statistically significant association of the Int7G24A variant with CRC susceptibility, for those individuals younger than 70 years (P for trend = 0.004). No statistically significant association was found between this polymorphism and individuals aged over 70 years (Table 1).
###end p 29
###begin p 30
###xml 18 29 18 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Int7G24G&gt;A </italic>
###xml 0 41 0 41 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Genotyping of the <italic>Int7G24G&gt;A </italic>polymorphism</bold>
Genotyping of the Int7G24G>A polymorphism. (A) Real-time PCR for allelic discrimination. (B) Direct sequencing to confirm the genotypes.
###end p 30
###begin p 31
###xml 17 26 17 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Int7G24A </italic>
Genotypes of the Int7G24A polymorphism in cases and controls and their association with CRC.
###end p 31
###begin p 32
###xml 5 7 3 5 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 </sup>
###xml 16 18 14 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p </italic>
* chi2 test; ** p for trend (Armitage's trend test)
###end p 32
###begin p 33
###xml 172 181 172 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Int7G24A </italic>
###xml 205 207 205 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 289 298 289 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Int7G24A </italic>
###xml 387 388 387 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 91 96 <span type="species:ncbi:9606">women</span>
###xml 200 203 <span type="species:ncbi:9606">men</span>
The results after gender adjustment were clear-cut, with no CRC risk association found for women and a strong statistically significant association for the presence of the Int7G24A variant and CRC in men (P for trend = 0.00023). The ORs for heterozygous and homozygous individuals for the Int7G24A variant were 1.74 (95% CI: 1.19-2.54) and 4.10 (95% CI: 1.41-11.85), respectively (Table 1). No significant associations were found between different genotypes and tumour location or stage.
###end p 33
###begin title 34
###xml 11 19 11 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Int7G24 </italic>
###xml 23 31 23 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Int7A24 </italic>
Lengths of Int7G24 and Int7A24 transcripts
###end title 34
###begin p 35
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G/G </italic>
###xml 51 55 51 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A/A </italic>
###xml 82 91 82 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Int7G24A </italic>
We performed mRNA analysis from homozygous G/G and A/A individuals to test if the Int7G24A variant might be related to an abnormal mRNA splicing that could explain the function of this allele as a risk factor for CRC. However, the mRNA fragments obtained always had the expected size for normal mRNA splicing independently of the genotype.
###end p 35
###begin title 36
Discussion
###end title 36
###begin p 37
###xml 83 84 80 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 286 288 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 295 311 292 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBR1_Int7G24A </italic>
###xml 429 435 426 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al </italic>
###xml 436 437 433 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 580 586 577 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al </italic>
###xml 587 588 584 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 824 825 821 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 871 873 868 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 912 914 909 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 1007 1016 1004 1013 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Int7G24A </italic>
###xml 1157 1159 1154 1156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 1227 1236 1224 1233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Int7G24A </italic>
The TGFbeta pathway plays an important role in tumour development and progression [1]. Recently, there has been interest in the contribution of genetic variation in this pathway to cancer susceptibility. Several polymorphic variants in genes involved in this pathway have been studied [12]. The TGFBR1_Int7G24A variant has been previously associated with cancer risk, but the role of this variant has yet to be discovered. Zhang et al [7] reported that homozygous but not heterozygous carriers of this variant have an increased risk of developing non-small cell lung cancer. Chen et al [9] reported the association of this variant with the incidence of renal cell carcinomas (OR: 2.2; 95% CI: 1.22-3.96) and transitional cell carcinoma of the bladder (OR: 2.45; 95% CI: 1.8-3.16). In a meta-analysis of these three studies [8], the pooled OR was 1.76 (95% CI: 1.33-2.34; P < 0.0001). Another case-control study [10] found an association with breast cancer (OR: 2.42; 95% CI: 1.55-3.79), suggesting that the Int7G24A variant could also represent a risk factor for invasive and metastatic breast cancers (OR: 2.61; 95% CI: 1.65-4.11). Skoglund-Lundin et al. [11] did not detect a significant association between CRC risk and the Int7G24A variant when they analysed data from cases with a familial history of colorectal cancer. The expectedly low-penetrance effect of this putative susceptibility allele would be very difficult to detect in cases with high-penetrance alleles. Moreover, the authors did not stratify their data according to sex.
###end p 37
###begin p 38
An exclusion criterion for the present study was the diagnosis of any familial cancer syndrome predisposing to CRC, such as hereditary non-polyposis colorectal cancer, familial adenomatous polyposis, Cowden disease and Peutz-Jeghers syndrome. We were interested to evaluate the effect of this SNP for sporadic CRC susceptibility and tumour progression. The potential effect of the SNP on familial syndromes as modifier of the penetrance, or the phenotype expression should be approached independently in further specific studies.
###end p 38
###begin p 39
###xml 45 53 <span type="species:ncbi:9606">patients</span>
###xml 271 279 <span type="species:ncbi:9606">patients</span>
Control individuals were selected from those patients treated at an emergency department with diverse non-cancerous pathologies and with no personal history of cancer. The probability that controls suffered from diseases putatively caused by the same risk factors as the patients with CRC is extremely low.
###end p 39
###begin p 40
###xml 181 189 181 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A priori</italic>
###xml 280 284 280 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G/A </italic>
###xml 363 367 363 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A/A </italic>
###xml 775 784 775 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Int7G24A </italic>
###xml 913 922 913 922 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Int7G24A </italic>
###xml 996 997 996 997 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
It is well known that one of the main limitations and sources of confounding the results in association studies comes from population stratification and inappropriate sample sizes. A priori, our study with 504 sporadic cases and 504 controls allowed us to detect an OR of 1.5 for G/A heterozygous individuals (considering a frequency of 0.3) and an OR of 2.0 for A/A homozygous individuals (considering a frequency of 0.025) with 80% power (two-sided test, alpha level 5%). Estimated genotype frequencies were obtained as preliminary results in a subset of our control population and were similar to the frequencies registered at the SNP database for European populations . The results presented here show an increase of CRC susceptibility for those individuals carrying the Int7G24A variant allele with a dosage effect (additive model of inheritance). Adjusting the OR by age, we only observed an association of Int7G24A variant carriers with CRC risk in subjects aged less than 70 years (Table 1). Thus, the genetic risk effect is more evident in younger individuals. Ageing implies a huge amount of acquired predisposing carcinogenic factors that could overshadow the mild effect of the susceptibility alleles.
###end p 40
###begin p 41
###xml 65 74 65 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Int7G24A </italic>
###xml 373 379 373 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al </italic>
###xml 380 382 380 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 961 963 958 960 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 123 126 <span type="species:ncbi:9606">men</span>
###xml 135 140 <span type="species:ncbi:9606">women</span>
###xml 514 519 <span type="species:ncbi:9606">women</span>
###xml 531 534 <span type="species:ncbi:9606">men</span>
###xml 659 662 <span type="species:ncbi:9606">men</span>
###xml 675 680 <span type="species:ncbi:9606">women</span>
When we analysed the data adjusting by gender, we found that the Int7G24A variant was strongly associated with CRC risk in men but not women. We do not know why. Evidence is accumulating supporting gender-related differences in the development of CRC, but to our knowledge, few reports have been published regarding sex-specific relationship between SNPs and CRC. Slattery et al [13] reported that the oestrogen receptor beta CA repeat polymorphism was associated with an increase relative risk of colon cancer in women but not in men. On the contrary, increasing number of CAG repeats in the androgen receptor was directly associated with colon cancer among men, but not in women. Both oestrogen and androgen receptors are present in colorectal tissue and it has been suggested that these might be important in regulating the CRC risk associated with these hormones. Activation of the TGFbeta signal transduction system is also subject to hormonal regulation [14]. This striking connection might suggest the involvement of sex steroid hormones acting through the TGFbeta pathway in the aetiology of CRC.
###end p 41
###begin p 42
###xml 214 216 214 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 223 229 223 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al </italic>
###xml 230 232 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 344 356 344 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VEGF 936 C&gt;T</italic>
###xml 561 566 561 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EGFR </italic>
###xml 667 669 667 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 786 788 786 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 797 799 797 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 811 813 811 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 134 137 <span type="species:ncbi:9606">men</span>
###xml 207 212 <span type="species:ncbi:9606">women</span>
###xml 463 468 <span type="species:ncbi:9606">women</span>
###xml 480 483 <span type="species:ncbi:9606">men</span>
###xml 627 635 <span type="species:ncbi:9606">patients</span>
The apolipoprotein E (ApoE) epsilon 2/3 polymorphism is another example of gender-specific modulation of CRC risk and prognosis where men have a highly significant association but there is no association in women [15]. Bae et al [16] found a gender-specific association between polymorphisms of the gene for vascular endothelial growth factor (VEGF 936 C>T) and CRC in the Korean population. T allele-bearing genotypes significantly increased the risk for CRC in women but not in men. Moreover, there are gender-related survival differences in association with EGFR (gene for epidermal growth factor receptor) polymorphisms in patients with metastatic colon cancers [17]. Again, oestrogens and androgens may be behind all these associations because of their functional links with ApoE [18], VEGF [19] and EGFR [20].
###end p 42
###begin p 43
###xml 209 211 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
It is possible that the positive associations shown here were not based on real effects of this polymorphism, but rather reflect unknown differences in population ancestry between the case and control groups [21]. We consider the probability of false-positive inference attributable to population stratification to be small, because the cases and control individuals were recruited from an ethnically homogeneous population with no indication of a significant amount of recent genetic admixture.
###end p 43
###begin p 44
###xml 281 283 281 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 830 839 830 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro </italic>
###xml 904 913 904 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Int7G24A </italic>
###xml 1002 1011 1002 1011 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Int7G24A </italic>
###xml 1020 1022 1020 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 1327 1336 1327 1336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Int7G24A </italic>
###xml 1371 1378 1371 1378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBR1 </italic>
###xml 1484 1494 1484 1494 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBR1*6A </italic>
###xml 1618 1625 1618 1625 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBR1 </italic>
###xml 1631 1633 1631 1633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 1699 1722 1699 1722 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBR1*6A and Int7G24A </italic>
###xml 492 500 <span type="species:ncbi:9606">patients</span>
###xml 644 649 <span type="species:ncbi:9606">women</span>
###xml 1124 1132 <span type="species:ncbi:9606">patients</span>
Given our results and those in the literature, it seems reasonable to speculate that there might be a gender-dependent allelic architecture for CRC risk associated with sex steroids. This would introduce a new level of complexity in the 'common disease-common variant' hypothesis [22]. Our association studies between this polymorphism and clinicopathological factors did not show any statistically significant results. The lack of difference in genotype distribution between male and female patients with CRC might be attributed to the contribution and compensation of other gender-related susceptibility polymorphisms, where the risks affect women preferentially. To date, how this intronic SNP affects oncogenesis remains to be elucidated. It has been proposed that this SNP creates an alternative splice site within intron 7. In vitro analysis with breast and ovarian cell lines from carriers of the Int7G24A variant have shown the retention of the seventh intron in the mRNA up to the site of the Int7G24A variant [23]. We wanted to study if this alternative splicing also occurred in the normal colorectal tissue from patients with CRC. However, we concluded that factors other than alternative splicing might account for the association of this polymorphism with cancer, although we cannot rule out the possibility that Int7G24A variant is a marker representing a TGFBR1 haplotype. In this regard, it is interesting to note the likely 'bystander susceptibility effect' for the TGFBR1*6A allele because of linkage disequilibrium with the unknown causative mutation of the allele-specific expression (ASE) in the TGFBR1 gene [24]. In our series, no linkage disequilibrium was found between the TGFBR1*6A and Int7G24A variant (unpublished results). No information is available regarding the association between variant and ASE. Further studies are required to characterize the molecular mechanisms by which variant is involved in gender-specific susceptibility to CRC.
###end p 44
###begin title 45
Conclusion
###end title 45
###begin p 46
###xml 59 75 59 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBR1_Int7G24A </italic>
The results of the present study strongly suggest that the TGFBR1_Int7G24A allele does confer an increased risk of colorectal cancer in the male Spanish population. The growing list of gender-dependent association of allelic variants and the risk of colorectal cancer might suggest the involvement of sex steroid hormones in the aetiology of CRC.
###end p 46
###begin title 47
Competing interests
###end title 47
###begin p 48
The authors declare that they have no competing interests.
###end p 48
###begin title 49
Authors' contributions
###end title 49
###begin p 50
AC participated in its design and coordination, in the molecular genetic studies and helped to draft the manuscript. TM-B, CG, M-IC, AM-C, V-MB participated in the molecular genetic studies and helped to draft the manuscript. PM participated in the design of the study, performed the statistical analysis and helped to draft the manuscript. EO, RL participated in samples biobanking and helped to draft the manuscript. CG-P, AC participated in the design of the study and performed the statistical analysis. J-LS conceived of the study, and participated in its design and coordination and drafted the manuscript. All authors read and approved the final manuscript.
###end p 50
###begin title 51
Pre-publication history
###end title 51
###begin p 52
The pre-publication history for this paper can be accessed here:
###end p 52
###begin p 53

###end p 53
###begin title 54
Acknowledgements
###end title 54
###begin p 55
This action has been performed within the cooperation framework established by the Transversal Cancer Action approved by the Council of Ministers on October 11th 2007 in accordance with the agreement between The Carlos III Health Institute (ISCIII), which is an autonomous entity currently belonging to the Ministry of Science and Innovation, and the Biomedical Research Foundation from the Hospital of Elche. Research supported in part by grants from the Generalitat Valenciana in Spain (AP106/06) and the Biomedical Research Foundation from the Hospital of Elche, Spain (FIBElx-02/2007). T.M-B is recipient of a fellowship from the Spanish Society of Medical Oncology (SEOM).
###end p 55
###begin article-title 56
Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer
###end article-title 56
###begin article-title 57
TGF-beta signaling alterations in cancer
###end article-title 57
###begin article-title 58
TGFbeta signaling in growth control, cancer, and heritable disorders
###end article-title 58
###begin article-title 59
TGFBR1*6A and cancer: a meta-analysis of 12 case-control studies
###end article-title 59
###begin article-title 60
Lack of an association between the TGFBR1*6A variant and colorectal cancer risk
###end article-title 60
###begin article-title 61
###xml 4 14 4 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TGFBR1*6A </italic>
The TGFBR1*6A allele is not associated with susceptibility to colorectal cancer in a Spanish population: a case-control study
###end article-title 61
###begin article-title 62
Mutational analysis of the transforming growth factor beta receptor type I gene in primary non-small cell lung cancer
###end article-title 62
###begin article-title 63
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Int7G24A </italic>
Int7G24A variant of the TGFBR1 gene and cancer risk: a meta-analysis of three case-control studies
###end article-title 63
###begin article-title 64
An intronic variant of the TGFBR1 gene is associated with carcinomas of the kidney and bladder
###end article-title 64
###begin article-title 65
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Int7G24A </italic>
Int7G24A variant of transforming growth factor-beta receptor type I is associated with invasive breast cancer
###end article-title 65
###begin article-title 66
TGFBR1 variants TGFBR1(*)6A and Int7G24A are not associated with an increased familial colorectal cancer risk
###end article-title 66
###begin article-title 67
Common gene polymorphisms, cancer progression and prognosis
###end article-title 67
###begin article-title 68
Associations between ERalpha, ERbeta, and AR genotypes and colon and rectal cancer
###end article-title 68
###begin article-title 69
TGF-beta signaling in breast cancer
###end article-title 69
###begin article-title 70
Apolipoprotein E gene polymorphism and colorectal cancer: gender-specific modulation of risk and prognosis
###end article-title 70
###begin article-title 71
Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936 C>T) gene and colon cancer in Korea
###end article-title 71
###begin article-title 72
Gender-related survival differences associated with EGFR polymorphisms in metastatic colon cancer
###end article-title 72
###begin article-title 73
Activation of estrogen receptor alpha increases and estrogen receptor beta decreases apolipoprotein E expression in hippocampus in vitro and in vivo
###end article-title 73
###begin article-title 74
Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells
###end article-title 74
###begin article-title 75
Minireview: nuclear receptors and breast cancer
###end article-title 75
###begin article-title 76
###xml 15 20 <span type="species:ncbi:9606">human</span>
The effects of human population structure on large genetic association studies
###end article-title 76
###begin article-title 77
###xml 28 33 <span type="species:ncbi:9606">human</span>
The allelic architecture of human disease genes: common disease-common variant...or not?
###end article-title 77
###begin article-title 78
Alternative splicing of a cancer-associated intronic variant of TGFBR1 in cancer cell lines
###end article-title 78
###begin article-title 79
Germline allele-specific expression of TGFBR1 confers an increased risk of colorectal cancer
###end article-title 79

